Elevation Oncology Statistics
Total Valuation
SHA:600136 has a market cap or net worth of CNY 3.98 billion. The enterprise value is 4.03 billion.
Market Cap | 3.98B |
Enterprise Value | 4.03B |
Important Dates
The next estimated earnings date is Saturday, August 30, 2025.
Earnings Date | Aug 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SHA:600136 has 2.04 billion shares outstanding.
Current Share Class | 2.04B |
Shares Outstanding | 2.04B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 8.02% |
Float | 1.13B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.19 |
PB Ratio | 13.56 |
P/TBV Ratio | 16.47 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -42.35 |
EV / Sales | 7.27 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -32.29 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.77.
Current Ratio | 1.34 |
Quick Ratio | 1.11 |
Debt / Equity | 0.77 |
Debt / EBITDA | n/a |
Debt / FCF | -1.81 |
Interest Coverage | -3.70 |
Financial Efficiency
Return on equity (ROE) is -30.27% and return on invested capital (ROIC) is -3.69%.
Return on Equity (ROE) | -30.27% |
Return on Assets (ROA) | -2.27% |
Return on Invested Capital (ROIC) | -3.69% |
Return on Capital Employed (ROCE) | -5.45% |
Revenue Per Employee | 728,593 |
Profits Per Employee | -125,126 |
Employee Count | 760 |
Asset Turnover | 0.73 |
Inventory Turnover | 10.44 |
Taxes
In the past 12 months, SHA:600136 has paid 3.94 million in taxes.
Income Tax | 3.94M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.48% in the last 52 weeks. The beta is 1.08, so SHA:600136's price volatility has been similar to the market average.
Beta (5Y) | 1.08 |
52-Week Price Change | +34.48% |
50-Day Moving Average | 2.05 |
200-Day Moving Average | 2.02 |
Relative Strength Index (RSI) | 37.97 |
Average Volume (20 Days) | 10,358,874 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600136 had revenue of CNY 553.73 million and -95.10 million in losses.
Revenue | 553.73M |
Gross Profit | 61.95M |
Operating Income | -27.36M |
Pretax Income | -99.66M |
Net Income | -95.10M |
EBITDA | -23.06M |
EBIT | -27.36M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 221.68 million in cash and 225.57 million in debt, giving a net cash position of -3.89 million or -0.00 per share.
Cash & Cash Equivalents | 221.68M |
Total Debt | 225.57M |
Net Cash | -3.89M |
Net Cash Per Share | -0.00 |
Equity (Book Value) | 293.58M |
Book Value Per Share | n/a |
Working Capital | 144.47M |
Cash Flow
In the last 12 months, operating cash flow was -109.80 million and capital expenditures -14.94 million, giving a free cash flow of -124.73 million.
Operating Cash Flow | -109.80M |
Capital Expenditures | -14.94M |
Free Cash Flow | -124.73M |
FCF Per Share | -0.06 |
Margins
Gross margin is 11.19%, with operating and profit margins of -4.94% and -17.17%.
Gross Margin | 11.19% |
Operating Margin | -4.94% |
Pretax Margin | -18.00% |
Profit Margin | -17.17% |
EBITDA Margin | -4.16% |
EBIT Margin | -4.94% |
FCF Margin | n/a |
Dividends & Yields
SHA:600136 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -2.39% |
FCF Yield | -3.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on May 12, 2016. It was a forward split with a ratio of 2.
Last Split Date | May 12, 2016 |
Split Type | Forward |
Split Ratio | 2 |
Scores
SHA:600136 has an Altman Z-Score of -3.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.14 |
Piotroski F-Score | 2 |